scaffolds |
Cep192 |
Spd-2 |
SPD-2 |
coiled coil, polo-box-binding domain |
centriole duplication defect, reduced PCM, PLK-1 targeting to centrosomes lost |
[13,26–28] |
Cep152 |
Asl (Asterless) |
|
coiled coil, SMC_prok_B (PFAM) |
centriole duplication defect, reduced PCM |
[29,14] |
CPAP |
SAS-4 |
SAS-4 |
coiled coil, tubulin binding |
centriole duplication defect, reduced PCM |
[30,31] |
PCNT |
D-PLP |
|
coiled coil, centrosome-targeting (PFAM) |
reduced PCM |
[12,32–34] |
CDK5RAP2 |
Cnn (centrosomin) |
|
coiled coil, MT association (PFAM) |
reduced PCM, centriole-PCM attachment defect |
[15,35–37] |
CG-NAP/AKAP450 |
|
|
coiled coil, calmodulin-binding domain |
centriole duplication defect |
[38,39] |
|
|
SPD-5 |
coiled coil, SMC_prok_B (PFAM) |
reduced PCM |
[16] |
kinases |
Plk1 (polo-like kinase 1) |
Plk1 |
PLK-1 |
kinase, polo-box |
reduced PCM, loss of phosphorylation of Cdk5Rap2/CNN, PCNT, and SPD-5 |
[40–43] |
AURKA (Aurora A kinase) |
Aurora A |
AIR-1 |
kinase |
centrosome separation defect, loss of effector recruitment (γ-tubulin, D-TACC, MSPS) |
[44–46] |
phosphatases |
PPP2ca |
PP2A |
LET-92 |
phosphatase |
centriole duplication defect, loss of MT stability via TPX2 and KLP-7, centrosome–nuclei detachment |
[47,48] |
PPP2r1a |
PP2A-B |
SUR-6 |
regulatory subunit of PP2A |
centriole duplication defect |
[49] |
|
|
RSA-1 |
regulatory subunit of PP2A |
loss of MT stability |
[47] |
|
|
RSA-2 |
regulatory subunit of PP2A |
loss of MT stability |
[47] |
PP4c |
PP4 |
PPH4.1 |
phosphatase |
abberant pericentrin foci, loss of effectors and kinases (α- and γ-tubulin, PLK-1, Aurora A) |
[50–53] |
effectors |
γ-tubulin |
γ-tubulin |
γ-tubulin |
tubulin |
impaired spindle assembly, impaired MT nucleation |
[3,54–57] |
TACC2 |
D-Tacc |
TAC-1 |
coiled coil (TACC domain) |
loss of effectors (ZYG-9/ZYG-8), loss of MT stability |
[58–61] |
CKAP5(chTOG) |
Msps |
ZYG-9 |
MT binding, TOG domain |
loss of MT stability, loss of centrosome integrity |
[61–64] |